Live data from Hacker News

Improvement in advanced Alzheimer’s disease following high-dose psilocybin

frontiersin.org

11–20 of 166 posts

Re: Improvement in advanced Alzheimer’s disease following high-dose psilocybin

#11
post #4

Not quite a "successful treatment": > This case documents transient multidomain functional improvement in advanced Alzheimer’s disease following psilocybin administration. The findings do not imply disease reversal but suggest that residual functional capacity may persist in late-stage neurodegeneration and may become transiently accessible under specific neuromodulatory conditions. Very interesting nonetheless. > On…

I'd love to see a before / after video of this or similar experiments, I'm really curious. I've seen similar ones for e.g. giving parkinsons' patients a dose of weed.

Re: Improvement in advanced Alzheimer’s disease following high-dose psilocybin

#12
post #6

> n=1 > pay to publish journal > no clear Alzheimers diagnosis ("[...] were considered clinically most compatible with advanced Alzheimer’s disease") > administration of a heroic dose of street-quality drugs vs. a controlled sample > no university or hospital affiliation? Extraordinary claims require extraordinary evidence, hence I remain skeptical

It’s a single case study so obviously take it with a grain of salt. On the other hand, it’s interesting and perhaps illuminating to people working in that field. A field mind you, that has made a little to no progress in decades. Arguments could be made they’ve made some errors and went down the wrong path. It’s a field that could probably use some new ideas.

Re: Improvement in advanced Alzheimer’s disease following high-dose psilocybin

#13
This case report is being shared widely across social media but it’s full of red flags from top to bottom.

It’s a case report (n=1) that a group of 3 people from Brazil wrote up and pushed into the publishing world. The report is full of big words and tables, but barely says anything more than the abstract: It’s basically “an 80 year old Japanese women received mushrooms and was better afterward” expanded with as much medical jargon as they could apply without accidentally getting too specific. No mention of how the Alzheimer’s disease history was documented or diagnosed or even if she was a patient of one of the authors.

I’m surprised how much it’s getting people to let their guard down and accept the result. Normally when studies get posted with only 100 to 500 participants the comments everywhere are full of doubters calling out the small sample size. For some reason this n=1 story written vaguely about extraordinary claims with a complete absence of pre-treatment documentation or standardize testing/scoring hits all the right notes to convince a lot of people that mushrooms can reverse Alzheimer’s disease.

I know it’s something that a lot of people would like to be true, but this is a domain where anyone in the world can make any claims they want and find a journal who will publish it if you pay them. People write and publish papers like this all the time claiming to have treated major diseases in a single patient or group of patients with different drugs or herbs.

Re: Improvement in advanced Alzheimer’s disease following high-dose psilocybin

#14

Good riddance - this kind of thing needs to be experimented with more. But 5 grams! This reads like witch doctor science; I’m surprised it passed ethics

While it’s a fairly good sized dose, it’s not one that would typically produce a nightmare trip scenario. As far as ethics go, I would absolutely sign a document that gives the right for experimentation in the event I become incapacitated to some degree.

5+ grams is considered a "heroic dose", i.e. the one that is needed for ego death and subsequent therapeutic effects.

Re: Improvement in advanced Alzheimer’s disease following high-dose psilocybin

#15

This case report is being shared widely across social media but it’s full of red flags from top to bottom. It’s a case report (n=1) that a group of 3 people from Brazil wrote up and pushed into the publishing world. The report is full of big words and tables, but barely says anything more than the abstract: It’s basically “an 80 year old Japanese women received mushrooms and was better afterward” expanded with as muc…

Sure, It’s a single case study so obviously take it with a grain of salt. Actual scientists understand this. People on social media don’t ands that’s annoying I get it.

On the other hand, it’s interesting and perhaps illuminating to people working in that field. A field mind you, that has made a little to no progress in decades. Arguments could be made they’ve made some errors and went down the wrong path. It’s a field that could probably use some new ideas.

Re: Improvement in advanced Alzheimer’s disease following high-dose psilocybin

#17
post #4

Not quite a "successful treatment": > This case documents transient multidomain functional improvement in advanced Alzheimer’s disease following psilocybin administration. The findings do not imply disease reversal but suggest that residual functional capacity may persist in late-stage neurodegeneration and may become transiently accessible under specific neuromodulatory conditions. Very interesting nonetheless. > On…

AFAIK psychedelics are thought to stimulate neurons into connecting with each other more than they normally do - both temporarily (which explains the short-term sensations) and also permanently (they stimulate neuroplasticity).

Re: Improvement in advanced Alzheimer’s disease following high-dose psilocybin

#18

Good riddance - this kind of thing needs to be experimented with more. But 5 grams! This reads like witch doctor science; I’m surprised it passed ethics

It's not just 5 grams of some random cubensis, it's 5 grams of the enigma strain, which is ridiculously potent.

Re: Improvement in advanced Alzheimer’s disease following high-dose psilocybin

#19
post #15

This case report is being shared widely across social media but it’s full of red flags from top to bottom. It’s a case report (n=1) that a group of 3 people from Brazil wrote up and pushed into the publishing world. The report is full of big words and tables, but barely says anything more than the abstract: It’s basically “an 80 year old Japanese women received mushrooms and was better afterward” expanded with as muc…

Sure, It’s a single case study so obviously take it with a grain of salt. Actual scientists understand this. People on social media don’t ands that’s annoying I get it. On the other hand, it’s interesting and perhaps illuminating to people working in that field. A field mind you, that has made a little to no progress in decades. Arguments could be made they’ve made some errors and went down the wrong path. It’s a fie…

> On the other hand, it’s interesting and perhaps illuminating to people working in that field

People in medicine or research have seen hundreds of extraordinary case reports like this. They’re everywhere on different topics and they’re not hard to get published.

They know that extraordinary claims require extraordinary evidence and it’s easy to see that this paper is completely devoid of evidence, just some extraordinary claims written in formal medical language, minus the usual process, methodology, and assessments one would expect in a paper like this.

Re: Improvement in advanced Alzheimer’s disease following high-dose psilocybin

#20

Good riddance - this kind of thing needs to be experimented with more. But 5 grams! This reads like witch doctor science; I’m surprised it passed ethics

Yeah this story was on HN before a few weeks ago and I raised similar - it’s nuts to give that to someone who probably doesn’t have the mental state to be able to comprehend what is going on. Don’t understand how it is possibly ethical to do.

Especially with the effects being temporary - can you imagine how awful it must be to regain lucidity outside of your control and then lose it again for the sake of an experiment like this? Awful experiment.

Post reply on HN